The Rehovot-based computational chemistry firm, which utilizes its proprietary ChemPass AI to design molecules for the pharmaceutical and agricultural sectors, faces a critical test of investor confidence. While the session is intended to review quarterly financial results, Nimrodi's participation signals an escalation in the company's response to the internal pressure. The call is set for 9:00 AM Eastern Time, with registration required for participants looking to monitor the discussion regarding these strategic developments.
Evogene Chairman to Address Shareholder Dispute in Upcoming Earnings Call
A brewing conflict between Evogene leadership and a faction of dissident shareholders will take center stage on August 18. Chairman Nir Nimrodi confirmed he will join the company’s quarterly earnings conference call to publicly address the group's recent maneuvers and outline the board's perspective on the potential impact to the firm.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!